Registered outcomes20

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 20 of 20

List	Outcome	Time frame	Description
Primary	The primary outcome is the proportion of patients achieving either SBP >100 mmHg or MAP > 65 mmHg or a target blood pressure set by the treating physician at 90 (±15) minutes after inclusion.	At 90 minutes	Bed-side assessment during treatment and registered in the case report form.
Secondary	Number of intensive care unit (ICU) free days alive within 30 days	At 30 days	Data is extracted from the Danish national registries or the patient's electronic medical record. Note: Death will count as 0 days.
Secondary	Time without shock within 24 hours	At 24 hours	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.
Secondary	30-day all-cause mortality	At 30 days	Data is extracted from the Danish national registries or the patient's electronic medical records.
Secondary	In-hospital all-cause mortality	At hospital discharge, an average of 30 days efter inclusion	Data is extracted from the Danish national registries or the patient's electronic medical records.
Other	Proportion of patients receiving vasopressor at any point within 24 hours	At 24 hours	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.
Other	Time to vasopressor initiation	At 30 days	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.
Other	Hours of vasopressor infusion	At 30 days	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.
Other	Proportion of patients with pulmonary oedema within 72 hours	At 72 hours	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.
Other	Proportion of patients with acute kidney failure within 72 hours	At 72 hours	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.
Other	Number of organ support free days alive within 30 days	At 30 days	Organ support is defined as either mechanical ventilation, vasopressor/inotrope therapy or dialsysis. Data is extracted from the Danish national registries or the patient's electronic medical record.
Other	Number of organ support free days alive within 30 days	At 30 days	Organ support is defined as either mechanical ventilation, vasopressor/intotropic therapy or dialysis. Note: Death will count as 0 days. Data is extracted from the Danish national registries or the patient's electronic medical record.
Other	Proportion of patients admitted to the ICU	At 30 days	Data is extracted from the patient's electronic medical records.
Other	ED Length of stay	At 72 hours	Data is extracted from the patient's electronic medical records.
Other	ICU length of stay	At 30 days	Data is extracted from the patient's electronic medical records.
Other	Hospital length of stay	At 30 days	Data is extracted from the patient's electronic medical records.
Other	Proportion and duration of mechanical ventilation	At 30 days	Data is extracted from the patient's electronic medical records.
Other	Proportion and length of renal replacement therapy	At 30 days	Data is extracted from the patient's electronic medical records.
Other	Amount of fluid therapy within the first 24 hours	At 24 hours	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.
Other	Proportion of serious adverse events for noradrenaline or fluid therapy, e.g. extravasation or overdosis of noradrenaline, pulmonary edema, new cardiac arrhytmias, during the intervention of control period	At 24 hours	Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05931601/registered

API reference For AI assistants